Key Takeaways It was a second straight day of gains for Eli Lilly shares following the drugmaker’s blowout second-quarter earnings…
Read More »drugmakers
The U.S. is the most lucrative market for drugmakers, but they often pay more in taxes overseas. Jim Watson/AFP via…
Read More »